T1	Participants 69 103	patients with aortic valve disease
T2	Participants 244 334	40 patients with aortic valve stenosis (AS) and 20 patients with aortic insufficiency (AI)
T3	Participants 775 791	patients with AS
T4	Participants 1348 1385	pancuronium-metocurine mixture group.
T5	Participants 1490 1506	patients with AI
T6	Participants 1922 1940	inpatients with Al
